ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "c622c951-6798-4577-9134-e9a4a4a412b1"}, "_deposit": {"id": "24688", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "24688"}, "status": "published"}, "_oai": {"id": "oai:nagoya.repo.nii.ac.jp:00024688", "sets": ["2036"]}, "item_9_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2017-08", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "3", "bibliographicPageEnd": "329", "bibliographicPageStart": "323", "bibliographicVolumeNumber": "79", "bibliographic_titles": [{"bibliographic_title": "Nagoya Journal of Medical Science"}]}]}, "item_9_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The Internet of Things (IoT) allows collecting vast amounts of health-relevant data such as daily activity, body weight (BW), and blood pressure (BP) automatically. The use of IoT devices to monitor diabetic patients has been studied, but could not evaluate IoT-dependent effects because health data were not measured in control groups. This multicenter, open-label, randomized, parallel group study will compare the impact of intensive health guidance using IoT and conventional medical guidance on glucose control. It will be conducted in outpatients with type 2 diabetes for a period of 6 months. IoT devices to measure amount of daily activity, BW, and BP will be provided to IoT group patients. Healthcare professionals (HCPs) will provide appropriate feedback according to the data. Non-IoT control, patients will be given measurement devices that do not have a feedback function. The primary outcome is glycated hemoglobin at 6 months. The study has already enrolled 101 patients, 50 in the IoT group and 51 in the non-IoT group, at the two participating outpatient clinics. The baseline characteristics of two groups did not differ, except for triglycerides. This will be the first randomized, controlled study to evaluate IoT-dependent effects of intensive feedback from HCPs. The results will validate a new method of health-data collection and provision of feedback suitable for diabetes support with increased effectiveness and low cost.", "subitem_description_type": "Abstract"}]}, "item_9_identifier_60": {"attribute_name": "URI", "attribute_value_mlt": [{"subitem_identifier_type": "URI", "subitem_identifier_uri": "http://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/793.html"}, {"subitem_identifier_type": "HDL", "subitem_identifier_uri": "http://hdl.handle.net/2237/26910"}]}, "item_9_identifier_registration": {"attribute_name": "ID登録", "attribute_value_mlt": [{"subitem_identifier_reg_text": "10.18999/nagjms.79.3.323", "subitem_identifier_reg_type": "JaLC"}]}, "item_9_publisher_32": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Nagoya University Graduate School of Medicine, School of Medicine"}]}, "item_9_select_15": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_9_source_id_7": {"attribute_name": "ISSN(print)", "attribute_value_mlt": [{"subitem_source_identifier": "0027-7622", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Onoue, Takeshi"}], "nameIdentifiers": [{"nameIdentifier": "73210", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Goto, Motomitsu"}], "nameIdentifiers": [{"nameIdentifier": "73211", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kobayashi, Tomoko"}], "nameIdentifiers": [{"nameIdentifier": "73212", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tominaga, Takashi"}], "nameIdentifiers": [{"nameIdentifier": "73213", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ando, Masahiko"}], "nameIdentifiers": [{"nameIdentifier": "73214", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Honda, Hiroyuki"}], "nameIdentifiers": [{"nameIdentifier": "73215", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yoshida, Yasuko"}], "nameIdentifiers": [{"nameIdentifier": "73216", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tosaki, Takahiro"}], "nameIdentifiers": [{"nameIdentifier": "73217", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yokoi, Hisashi"}], "nameIdentifiers": [{"nameIdentifier": "73218", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kato, Sawako"}], "nameIdentifiers": [{"nameIdentifier": "73219", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Maruyama, Shoichi"}], "nameIdentifiers": [{"nameIdentifier": "73220", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Arima, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "73221", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2018-02-22"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "05_Onoue.pdf", "filesize": [{"value": "1.2 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1200000.0, "url": {"label": "05_Onoue.pdf", "url": "https://nagoya.repo.nii.ac.jp/record/24688/files/05_Onoue.pdf"}, "version_id": "4e98095c-1a23-4012-800c-e6e59303bba5"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "type 2 diabetes", "subitem_subject_scheme": "Other"}, {"subitem_subject": "health guidance", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Internet of Things", "subitem_subject_scheme": "Other"}, {"subitem_subject": "wearable device", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Randomized controlled trial for assessment of Internet of Things system to guide intensive glucose control in diabetes outpatients : Nagoya Health Navigator Study protocol", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Randomized controlled trial for assessment of Internet of Things system to guide intensive glucose control in diabetes outpatients : Nagoya Health Navigator Study protocol"}]}, "item_type_id": "9", "owner": "1", "path": ["2036"], "permalink_uri": "https://doi.org/10.18999/nagjms.79.3.323", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-08-23"}, "publish_date": "2017-08-23", "publish_status": "0", "recid": "24688", "relation": {}, "relation_version_is_last": true, "title": ["Randomized controlled trial for assessment of Internet of Things system to guide intensive glucose control in diabetes outpatients : Nagoya Health Navigator Study protocol"], "weko_shared_id": null}
  1. C100 医学部/医学系研究科
  2. C100b 紀要
  3. Nagoya journal of medical science
  4. 79(3)

Randomized controlled trial for assessment of Internet of Things system to guide intensive glucose control in diabetes outpatients : Nagoya Health Navigator Study protocol

https://doi.org/10.18999/nagjms.79.3.323
https://doi.org/10.18999/nagjms.79.3.323
c12629b4-6e6f-4849-b639-6a7d1dd089ae
名前 / ファイル ライセンス アクション
05_Onoue.pdf 05_Onoue.pdf (1.2 MB)
Item type 紀要論文 / Departmental Bulletin Paper(1)
公開日 2017-08-23
タイトル
タイトル Randomized controlled trial for assessment of Internet of Things system to guide intensive glucose control in diabetes outpatients : Nagoya Health Navigator Study protocol
著者 Onoue, Takeshi

× Onoue, Takeshi

WEKO 73210

Onoue, Takeshi

Search repository
Goto, Motomitsu

× Goto, Motomitsu

WEKO 73211

Goto, Motomitsu

Search repository
Kobayashi, Tomoko

× Kobayashi, Tomoko

WEKO 73212

Kobayashi, Tomoko

Search repository
Tominaga, Takashi

× Tominaga, Takashi

WEKO 73213

Tominaga, Takashi

Search repository
Ando, Masahiko

× Ando, Masahiko

WEKO 73214

Ando, Masahiko

Search repository
Honda, Hiroyuki

× Honda, Hiroyuki

WEKO 73215

Honda, Hiroyuki

Search repository
Yoshida, Yasuko

× Yoshida, Yasuko

WEKO 73216

Yoshida, Yasuko

Search repository
Tosaki, Takahiro

× Tosaki, Takahiro

WEKO 73217

Tosaki, Takahiro

Search repository
Yokoi, Hisashi

× Yokoi, Hisashi

WEKO 73218

Yokoi, Hisashi

Search repository
Kato, Sawako

× Kato, Sawako

WEKO 73219

Kato, Sawako

Search repository
Maruyama, Shoichi

× Maruyama, Shoichi

WEKO 73220

Maruyama, Shoichi

Search repository
Arima, Hiroshi

× Arima, Hiroshi

WEKO 73221

Arima, Hiroshi

Search repository
キーワード
主題Scheme Other
主題 type 2 diabetes
キーワード
主題Scheme Other
主題 health guidance
キーワード
主題Scheme Other
主題 Internet of Things
キーワード
主題Scheme Other
主題 wearable device
抄録
内容記述 The Internet of Things (IoT) allows collecting vast amounts of health-relevant data such as daily activity, body weight (BW), and blood pressure (BP) automatically. The use of IoT devices to monitor diabetic patients has been studied, but could not evaluate IoT-dependent effects because health data were not measured in control groups. This multicenter, open-label, randomized, parallel group study will compare the impact of intensive health guidance using IoT and conventional medical guidance on glucose control. It will be conducted in outpatients with type 2 diabetes for a period of 6 months. IoT devices to measure amount of daily activity, BW, and BP will be provided to IoT group patients. Healthcare professionals (HCPs) will provide appropriate feedback according to the data. Non-IoT control, patients will be given measurement devices that do not have a feedback function. The primary outcome is glycated hemoglobin at 6 months. The study has already enrolled 101 patients, 50 in the IoT group and 51 in the non-IoT group, at the two participating outpatient clinics. The baseline characteristics of two groups did not differ, except for triglycerides. This will be the first randomized, controlled study to evaluate IoT-dependent effects of intensive feedback from HCPs. The results will validate a new method of health-data collection and provision of feedback suitable for diabetes support with increased effectiveness and low cost.
内容記述タイプ Abstract
出版者
出版者 Nagoya University Graduate School of Medicine, School of Medicine
言語
言語 eng
資源タイプ
資源 http://purl.org/coar/resource_type/c_6501
タイプ departmental bulletin paper
ID登録
ID登録 10.18999/nagjms.79.3.323
ID登録タイプ JaLC
ISSN(print)
収録物識別子タイプ ISSN
収録物識別子 0027-7622
書誌情報 Nagoya Journal of Medical Science

巻 79, 号 3, p. 323-329, 発行日 2017-08
著者版フラグ
値 publisher
URI
識別子 http://www.med.nagoya-u.ac.jp/medlib/nagoya_j_med_sci/793.html
識別子タイプ URI
URI
識別子 http://hdl.handle.net/2237/26910
識別子タイプ HDL
戻る
0
views
See details
Views

Versions

Ver.1 2021-03-01 13:56:29.198747
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3